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Abstract
Background: To evaluate the long-term outcomes of Argon laser photocoagulation compared to surgical direct
cyclopexy in small-size cyclodialysis cleft patients.
Methods: This is a retrospective study. Small-size cyclodialysis cleft patients who underwent Argon laser
photocoagulation and surgical direct cyclopexy were reviewed. The mean follow-up period were 82.4 (range, 61 – 145)
months and 99.9 (range, 62 – 184) months in both groups. The comparison of best corrected visual acuity (BCVA),
intraocular pressure (IOP), postoperative peak IOP and time to normalization of IOP before and after the treatment.
Results: The causes of all included 15 cyclodialysis cleft cases were blunt trauma. seven patients underwent Argon laser
photocoagulation and eight patients underwent surgical direct cyclopexy. The mean age of included patients was not
significantly different (p = 0.38). Preoperatively, the mean logMAR BCVA (standard deviation, SD) was 0.7 (0.2) and 1.1 (0.9)
and mean IOP was 4.4 (2.4) mmHg and 3.0 (1.5) mmHg in Argon laser group and surgical direct cyclopexy group (p= 0.24
and p= 0.18, respectively). The extension of cyclodialysis and duration of cyclodialysis cleft were not significantly different
between the two groups (p= 0.08 and p= 0.24, respectively). The mean follow-up period were 82.4 (range, 61 – 145)
months and 99.9 (range, 62 – 184) months in both groups (p= 0.41). Postoperatively, the mean logMAR BCVA was 0.0 (0.1)
and 0.2 (0.3) and mean IOP was 14.5 (3.1) mmHg and 16.8 (2.5) mmHg (p= 0.15 and p= 0.16, respectively). Postoperative
peak IOP and time to normalization of IOP were not different between the two groups (p= 0.75 and p= 0.91, respectively).
Discussion: It is necessary to use invasive treatment such as cryotherapy or surgical direct cyclopexy in cyclodialysis cleft
with hypotonic maculopathy. In the present study, Argon laser photocoagulation showed good prognosis in a small-size
cyclodialysis cleft below 1.5 clock-hours. Considering possible complications and cost of surgical direct cyclopexy, Argon
laser can be more beneficial than surgical direct cyclopexy in small-size cyclodialysis cleft below 1.5 clock-hours.
Conclusions: The clinical ourcome of Argon laser photocoagulation seems to be as good as surgical direct cyclopexy in
small-size cyclodialysis cleft below 1.5 clock-hours.
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Background
Cyclodialysis cleft occurs when the ciliary body is detached
from the scleral spur. This is usually related to blunt
trauma or iatrogenic injury due to ophthalmic surgery. The
communication between the anterior chamber and the
suprachoroidal space can result in clinically significant
hypotony and its complications such as cataract or macular
edema [1]. Clinically, direct suture closure is usually used
for repair [2, 3]. However, several alternative methods for
closing a cyclodialysis cleft have been used, including
penetrating diathermy [4], Argon laser photocoagulation
[5], cryotherapy [6, 7], scleral buckling [8], and vitrectomy
with gas tamponade [9].
Laser photocoagulation using Argon laser has been used
as one of the treatment of choice for repair of cyclodialysis
cleft to avoid major intraocular surgeries [10]. Previously,
Argon laser photocoagulation in cyclodialysis cleft was
introduced by Joondpth [11]. He reported one small-size
cyclodialysis cleft case who recovered visual acuity and
intraocular pressure (IOP) after Argon laser photocoagula-
tion treatment twice. Harbin also reported that three
small-size cyclodialysis cleft patients treated by Argon laser
photocoagulation showed good prognosis [12]. However,
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the follow-up periods of the previous reports were rela-
tively short (2 months to 2 years), there are no long-term
outcomes of the Argon laser photocoagulation in small-
size cyclodialysis cleft. Therefore, we intended to investigate
the long-term outcomes of Argon laser photocoagulation
compared to surgical direct cyclopexy in small-size cyclo-
dialysis cleft patients.
Methods
The present study was retrospective study approved by the
Institutional Review Board of Samsung Medical Center and
adhered to the tenets of the Declaration of Helsinki. The
medical charts of the traumatic cyclodialysis cleft patients
who visited Samsung Medical Center and underwent
Argon laser photocoagulation from January 1999 to
December 2008 were reviewed.
We included the patients with small-size cyclodialysis
cleft below the extent of 2 clock-hours. A single surgeon
(CK) performed all the Argon laser treatment and surgical
direct cyclopexy. All included patients with small-size cyclo-
dialysis cleft used atropine at least for 2 months at first. In
case the patients had no improvement of the symptoms of
cyclodialysis cleft such as persistent ocular hypotony with
decreased visual acuity or macula edema with medical
treatment, they underwent Argon laser photocoagulation or
surgical direct cyclopexy. The decision which methods the
patient would undergo was made by the patient after
explaining the strength and weakness of the each treatment.
We only included the cases with medical records over five
years after the treatment. The cases with severe ocular com-
plications such as scleral laceration and choroidal rupture
were excluded. The treatments were fully explained to each
patient, and each provided written informed consent.
All patients underwent routine ophthalmologic examina-
tions including best-corrected visual acuity (BCVA), slit-
lamp examination, Goldmann applanation tonometry and
fundus photo. Gonioscopic examination and ultrasound
biomicroscopy (UBM) (Fig. 1a and b) were used in all pa-
tients for confirmation of the location and extent of cyclo-
dialysis cleft before laser treatment. After the treatment,
the patients underwent ophthalmologic examinations such
as BCVA, Goldmann applanation tonometry, gonioscopic
examination and fundus examination at 1 week, 1 month
and 3 months, and every 6 month. UBM was performed
at 3 month after the treatment. Follow-up period was
regarded as the duration between initial visit and last visit
to outpatient clinic for cyclodialysis cleft. Duration of
cyclodialysis cleft before treatment (DOC), postoperative
maximum IOP and time to IOP normalization (TNP) were
evaluated. Normalized IOP was defined as the IOP be-
tween 10 and 21 mmHg.
Argon laser photocoagulation
The procedure was performed on the outpatient clinic.
Retrobulbar anesthesia using 2 % lidocaine was used. If the
anterior chamber is too shallow, it was deepend with
ophthalmic viscosurgical device (OVD), Hyal 2000® (so-
dium hyaluronate 1.0 %, LG life sciences, Co., Ltd). The
location and extent of cyclodialysis cleft was confirmed by
gonioscopy and Argon laser was applied to the full extent
of the cleft. The protocol of Argon laser photocoagulation
(GYC-1000, Nidek, Co., Ltd) in our clinic was as follows: at
first, the laser targeted for bare sclera detached from ciliary
body. The recommended spot size was 300 to 500 μm,
duration of 0.3 to 0.5 s and the power ranged between 800
and 1000 mW. The green color of laser (532 nm) was used.
The number of burns was approximately 40 to 50 shots.
And then, the target of laser changed into the area that
contains iris root and detached ciliary body. The spot size
also changed into 100 μm with a duration of 0.1 to 0.2 s
and the power ranged between 600 and 800 mW. The
number of burns was approximately 40 to 50 shots. The
laser power was titrated based on the tissue response. We
regarded bubble formation around tissue as the proper
Fig. 1 Case A2, A 31-year-old man presented with deteriorated visual acuity of the left eye after blunt trauma. a Cyclodialysis cleft was
found on preoperative ultrasound biomicroscopy (UBM). b Closed cyclodialysis cleft was found on UBM at three months after Argon
laser photocoagulation
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tissue response of an effective laser treatment. If pop sound
with bubble formation occurred, the power was decreased.
The number of burns was usually totally 80 to 100 shots.
After the procedure, patients used 1 % atropine for one
month. Because of temporary IOP increase, a topical β-
blocker, an oral carbonic anhydrase inhibitor, or an intra-
venous hyperosmotic agent was used. If the IOP was still
low at 1 week, additional Argon laser photocoagulation
was performed as the same method mentioned above.
Surgical direct cyclopexy
A conjunctival flap was made and the sclera was exposed
at the site of the cyclodialysis cleft. A partial-thickness
scleral flap was made approximately 4 mm posterior to the
limbus. After elevating the scleral flap, the sclera was in-
cised 1.5 mm posterior and parallel to the limbus. Aqueous
humor was released, and the cyclodialysis cleft was visual-
ized. The detached ciliary body was attached to the sclera
with an interrupted suture through the anterior sclera, the
ciliary body, and the posterior scleral lip using 10–0 nylon
sutures. The scleral flap and conjunctiva were closed. After
the surgery, 1 % atropine was used in eyes. Because of
temporary IOP increase, a topical β-blocker, an oral car-
bonic anhydrase inhibitor, or an intravenous hyperosmotic
agent was used.
Statistical analysis
Independent t-test or Mann–Whitney U-test was used for
comparison of the clinical characteristics between Argon
laser photocoagulation group and surgical direct cyclopexy
group. Clinical characteristics that were compared between
the two groups were as follows: Age, extent of cyclodialysis
cleft, DOC, preoperative and postoperative final BCVA and
IOP, postoperative maximum IOP, TNP, and follow-up
period. Statistical analyses were performed using 18.0 (SPSS
Inc., Chicago, Illinois, USA). The results were considered
significant at p-values < 0.05.
Results
Twenty-one patients with a small-size cyclodialysis cleft
were investigated. Five cases were excluded because they
were accompanied by ocular problems such as scleral lacer-
ation and choroidal rupture. Among 16 patients, one case
was recovered from hypotony only using 1 % atropine for a
month. Argon laser photocoagulation for cyclodialysis repair
was performed in seven eyes of seven patients. Surgical dir-
ect cyclopexy were performed in eight eyes of eight patients.
The cause of all cyclodialysis cleft cases treated by Argon
laser or surgical cyclopexy was blunt trauma. The mean
(standard deviation, SD) age of included patients was 33.3
(15.2) years (range, 14 – 50 years) and 40.8 (16.3) years
(range, 14 – 60 years) in Argon laser group and surgical dir-
ect cyclopexy group (p= 0.38). All the included patients were
men except one case in surgical direct cyclopexy group.
Preoperatively, the mean (SD) log minimum angle of
resolution (logMAR) BCVA were 0.7 (0.2) and 1.1 (0.9) and
mean (SD) IOP were 4.4 (2.4) mmHg (range, 1 – 7 mmHg)
and 3.0 (1.5) mmHg (range, 0 – 5 mmHg) in both groups
(p = 0.24 and p = 0.18, respectively). The mean extent of
cyclodialysis cleft were 1.2 (0.3) clock-hours (range, 1 – 1.5
clock-hours) and 1.6 (0.4) clock-hours (range, 1 – 2 clock-
hours) and the duration of cyclodialysis before laser treat-
ment were 6.1 (8.4) months (range, 2 – 25 months) and
2.0 (0.5) months (range, 1 – 3 months) in both groups
(p = 0.08 and p = 0.24, respectively). All patients except
one patient (Case A7) had hypotonic maculopathy before
the treatment.
Postoperatively, the mean (SD) final logMAR BCVA
were 0.0 (0.1) and 0.2 (0.3) and mean (SD) final IOP
were 14.5 (3.1) mmHg and 16.8 (2.5) mmHg in both
groups (p = 0.15 and p = 0.16, respectively). The mean
(SD) postoperative maximum IOP were 30.4 (13.4)
mmHg (range, 15 – 46 mmHg) and 32.8 (13.8) mmHg
(range, 17 – 50 mmHg) in both groups (p = 0.75). The
mean (SD) time to normalization of IOP were 9.6 (15.8)
days (range, 1 – 45 days) and 8.9 (6.9) days (range, 1 –
21 days) in both groups (p = 0.91). The mean (SD) follow-
up period were 82.4 (29.0) months (range, 61 – 145 days)
and 99.9 (47.1) months (range, 62 – 184 days) in both
groups (p = 0.41). There were no complications during the
laser treatments or surgeries. One patient (Case A3) in
Argon laser group had an additional Argon laser photo-
coagulation at 1 week after the first Argon laser treatment
due to persistent hypotony. Recurrence of hypotony, sec-
ondary glaucoma were not found during follow-up period.
The preoperative and postoperative demographics of the
cyclodialysis cleft patients are summarized in Table 1.
Discussion
In the present study, Argon laser photocoagulation showed
a good prognosis similar to surgical direct cyclopexy in
small-size cyclodialysis cleft below 1.5 clock-hours. No
significant differences in preoperative and postoperative
clinical characteristics were shown between Argon laser
photocoagulation group and surgical direct cyclopexy
group. Given that the Argon laser photocoagulation is
simpler and less expensive than surgical direct cyclo-
pexy, Argon laser photocoagulation would be a better
treatment of choice in small-size cyclodialysis cleft.
When the extent of the cyclodialysis cleft is not large, it is
possible to wait for spontaneous recovery using conserva-
tive treatment. Previously, several reports suggested that
conservative medical treatment was effective in small-size
cyclodialysis cleft. Ormerod et al. reported that 1 % atropine
can help to close the cleft by relaxation of the ciliary muscle
to sclera [13]. Joondeph et al. suggested that abrupt cessa-
tion of steroid can make inflammation and help to close
the cleft [11]. However, it is difficult to keep observation if
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the cyclodialysis cleft patients have hypotonic maculopa-
thy that is potentially vision threatening [10]. Visual acuity
cannot be recovered due to irreversible wrinkling and fi-
brosis of the retina [14, 15]. In our case, most of the cases
(93.3 %) showed hypotonic maculopathy in preoperative
examinations. In addition, it seems not to be effective only
using 1 % atropine even in small-size cyclodialysis. In our
present study, only one case (6.3 %) was recovered from
hypotony by using 1 % atropine only. Therefore, it would
be eventually necessary to use invasive treatment such as
cryotherapy and surgical direct cyclopexy even though the
extent of the cleft is small in cyclodialysis cleft.
Several treatment methods to close cyclodialysis cleft
have been introduced before. Surgical direct cyclopexy has
been known as the definite treatment of choice in cyclo-
dialysis cleft. However, it is invasive and takes longer and
costs more to perform [2, 3]. Transscleral diathermy is
also invasive. The surgeon should create a partial thickness
scleral flap prior to the application of the treatment and
has a risk of inducing thermal tissue damage [4, 16].
Transscleral diode photocoagulation and cryotherapy can
be another good treatment of choice. However, the device
such as a diode laser or a cryotherapy uncommonly used
in the outpatient clinic should be prepared. In this point
of view, Argon laser photocoagulation has some benefits
compared to other invasive methods. First, it can be
performed simply on the outpatient clinic basis. Argon
laser is more commonly used in outpatient clinic than
other devices mentioned above. Ophthalmologists are
usually accustomed to Argon laser because the common
laser treatments such as a panretinal photocoagulation or
a laser iridotomy are frequently performed on the out-
patient clinic basis. In terms of time, it takes shorter to
perform than other invasive procedures because it is not
necessary to make conjunctival flap or scleral flap. After
the anesthesia, the Argon laser photocoagulation can be
performed in a few minutes. In addition, it can be per-
formed with securing the view of the cleft directly during
the procedure. Therefore, it was possible for clinicians to
modulate the power and number of shots based on the
tissue reaction.
In previous reports, Argon laser setting was 0.1-0.2 s,
50–200 μm, 400–800 mW and 100 to 200 shots were
applied in one session [11, 12]. We used two different
settings of Argon laser photocoagulation based on the
target tissue response. We regarded bubble formation as
the good tissue response to the laser treatment. When
the bubble formation occurred, it was usually accompan-
ied by the slight melting changes of the target tissue. We
thought the melting changes of the tissues as the sign of
inducement of proper inflammation. In our experience,
the different settings based on the target tissues seemed





















Case A1 48/M 1.5 3 0.70/0.00 6/12 + 15 2 68
Case A2 31/M 1 2 1.00/0.10 7/14 + 46 7 61
Case A3 48/M 1 2 0.80/0.05 1/11 + 16a 2a 145
Case A4 21/M 1 6 0.80/0.05 4/15 + 40 3 75
Case A5 50/M 1.5 2 0.50/0.00 4/20 + 38 45 90
Case A6 14/M 1.5 3 0.50/0.00 2/17 + 40 7 68
Case A7 21/M 1 25 0.30/0.10 7/13 – 18 1 70
Average
(SD)




30.4 (13.4) 9.6 (15.8) 82.4 (29.0)
Surgical
Cyclopexy
Case S1 40/M 2 2 1.40/0.82 3/17 + 42 14 66
Case S2 49/M 1.5 2 0.52/0.05 5/20 + 45 21 65
Case S3 30/M 2 2 0.40/0.00 3/15 + 17 3 184
Case S4 27/F 1.5 2 1.00/0.00 2/18 + 30 3 154
Case S5 46/M 1 3 0.05/0.00 3/13 + 42 7 120
Case S6 60/M 1.5 2 1.70/0.52 4/20 + 18 8 76
Case S7 14/M 1 1 0.70/0.05 0/16 + 18 1 72
Case S8 60/M 2 2 3.00/0.30 4/15 + 50 14 62
Average
(SD)




32.8 (13.8) 8.9 (6.9) 99.9 (47.1)
No significant differences between the two groups, Independent t-test or Mann–Whitney U-test
BCVA Best corrected visual acuity, DOC Duration of cyclodialysis cleft before surgery, IOP Intraocular pressure, SD Standard deviation, TNP Time to normalization
of IOP
aMeasurements after secondary treatment
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good to make proper bubble formation on each target
tissues. The reason for this is yet to be certain, but we
speculate that the different target tissues with different
degrees of pigmentations may be the cause of different
requisite laser settings.
In terms of recovery, the two methods showed no clinic-
ally different results. Postoperative maximal IOP and time
to IOP normalization were not significantly different. Post-
operative maximal IOP and the time to IOP normalization
are important for clinicians to prevent complications asso-
ciated with hypertensive phase. Only one case (case A3) in
Argon laser group underwent the treatment because of
persistent hypotony associated with cyclodialysis cleft.
However, cyclodialysis cleft was sealed by additional Argon
laser photocoagulation and IOP have been maintained over
10 years.
Surgical treatment can burden the surgeons and patients.
Surgical treatment has substantial severe complications
such as endophthalmitis or suprachoroidal hemorrhage.
Furthermore, the conventional surgical direct cyclopexy
takes much longer time to be performed than Argon laser
photocoagulation. Even though there was no treatment
failure case when using direct cyclopexy in the present
study, several reports showed failure cases of direct cyclo-
pexy previously [8, 17]. Therefore it is not certain whether
early invasive treatment such as surgical direct cyclopexy is
clinically beneficial or not especially when the cleft size is
small. As a result, proper interventions to prevent irrevers-
ible maculopathy and fibrosis can be delayed. In this point
of view, Argon laser photocoagulation can be a good
choice for early intervention in small-size cyclodialysis
cleft.
Conclusion
In conclusion, the clinical ourcome of Argon laser photo-
coagulation seems to be as good as surgical direct cyclo-
pexy. Considering cost, time and possible complications
of surgical direct cyclopexy, Argon laser can be more
beneficial than surgical direct cyclopexy in small-size
cyclodialysis cleft below 1.5 clock-hours.
Consent
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(Case A2) for publication.
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